(Q51323708)

3 April 2018

title

Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). (English)

1 reference

3 April 2018

1 reference

Gareth D Healey

3

0 references

author name string

Angie Westwood

1

1 reference

3 April 2018

Stephen J Elvin

2

1 reference

3 April 2018

E Diane Williamson

4

1 reference

3 April 2018

Jim E Eyles

5

1 reference

3 April 2018

language of work or name

English

0 references

publication date

24 October 2005

1 reference

3 April 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

3 April 2018

volume

24

1 reference

3 April 2018

issue

11

1 reference

3 April 2018

page(s)

1736-1743

1 reference

3 April 2018

Toll-like receptor signalling

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Innate immunity and pathogen-host interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Toll-like receptors in the induction of the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Immunotherapeutic uses of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Therapeutics targeting the innate immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Recognition of single-stranded RNA viruses by Toll-like receptor 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The many ways to cross the plasma membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG motifs: the active ingredient in bacterial extracts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Interferon-producing cells: on the front line in immune responses against pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The function of type I interferons in antimicrobial immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Prospects for the development of new vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The molecular basis of T helper 1 and T helper 2 cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Manipulating the immune system: humoral versus cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

The therapeutic potential of antigen-oligonucleotide conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.021

10.1016/J.VACCINE.2005.10.021

7 January 2021

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018